Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

49 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

NCT06952660

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • HonorHealth Cancer Care - Biltmore - AZCCC Imaging Phoenix, Arizona, United States
  • HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy Phoenix, Arizona, United States
  • HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care -Biltmore Phoenix, Arizona, United States
  • Sonora Quest Laboratories, LLC Phoenix, Arizona, United States
View all 129 locations
View Trial Details
Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.

NCT04061967

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Northern Region Luleå, Norrbotten County, Sweden
  • Southern Region Lund, Skåne County, Sweden
  • Western Region Gothenburg, Västra Götaland County, Sweden
  • Southeast Region Jönköping, Sweden
View Trial Details
Completed

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

NCT03555422

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Florida Cancer Specialists (Sarah Cannon Research Institute) West Palm Beach, Florida, United States
View all 78 locations
View Trial Details

Related conditions